Back

The selective Rho Kinase 2 inhibitor Chroman-1, is a potent vasodilator but does not compromise left ventricular function in-vivo

25 August 2023 (16:15 - 16:50)
Organised by: Logo
Congress Presentation Part of: Vascular dysfunction Ischaemia, Infarction, Cardioprotection ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Lucie E Pearce

King's College London, London (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
A better understanding of coronary artery disease molecular biology through an intermediate phenotype
Doctor D. Sa (Funchal, PT)
Abstract Slides Video
Presentation thumbnail
South Asian adults with ASCVD exhibit a reduction in circulating vascular regenerative cell content compared to White European adults: a sub-analysis of the ORIGINS-RCE CardioLink-13 study.
Ms A. Krishnaraj (Toronto, CA)
Abstract Slides Video
Presentation thumbnail
Identification of the low wall shear stress area in the middle and distal coronary artery: a dynamic angiography and deep learning analysis
Doctor L. Vu (Long An, VN)
Abstract Slides Video
Presentation thumbnail
Endothelial junctional protein associated with coronary artery disease (JCAD) as a potential therapeutic target for acute ischemic stroke
Doctor S. Ministrini (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Therapeutic modulation of epigenetic readers rescues obesity-induced vascular dysfunction: role of endothelium and perivascular adipose tissue
Doctor A. Mengozzi (Pisa, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Vascular dysfunction

The Event

Event poster

ESC Congress 2023

25 August 2023 16:15 CET
You may be interested in
thumbnail
Congress Session
Young Investigator Award Session in Basic and Translational Sciences
thumbnail
Congress Session
Novel drugs for cardiovascular diseases
thumbnail
Congress Session
Therapeutic targets for myocardial infarction